Clinical Nutritional Therapy in Cystic Fibrosis: Dietary Architecture, Energy Density, and Pancreatic Enzyme Protocols

Cystic fibrosis is a monogenic autosomal recessive channelopathy triggered by mutations in the CFTR chloride-conducting epithelial pore. It primarily impacts respiratory architecture (viscous mucus impaction, bronchiectasis, bacterial biofilms), gastrointestinal organs (pancreatic ductal obstruction, focal biliary cirrhosis), and sweat glands.

Malnutrition in cystic fibrosis represents a complex multifactorial cascade:

• Elevated basal expenditure: Increased respiratory muscle work under high airway resistance and constitutive pulmonary inflammation drive hypermetabolism.
• Pancreatic malabsorption: Intraductal mucus plugs block pancreatic enzyme delivery (lipase, protease, amylase) to the duodenum, inducing severe steatorrhea and nitrogen loss.
• Hyporexia: Chronic persistent coughing, sputum ingestion, and circulating inflammatory cytokines suppress hypothalamic hunger centers.

In pediatric cohorts, undernutrition presents as failure to thrive, flat centile growth trajectories, and delayed pubertal and skeletal maturation. In adult cohorts, it manifests as accelerated sarcopenia, osteopenia, osteoporotic fractures, and CF-related diabetes (CFRD) secondary to endocrine islet fibrosis.

Key architectural parameters of CF dietary therapy:

• Caloric target: 120–150% of age-adjusted dietary reference values (typically 3,000–4,500 kcal/day).
• Elevated fat fraction: 35–45% of total caloric intake from high-quality sources (butter, virgin oils, fatty fish, MCT oils bypassing lipase).
• Protein enrichment: 2.0–3.0 g/kg body weight to preserve myofibrillar protein synthesis.
• Obligate NaCl supplementation: Liberal salting of all meals to compensate for defective sweat gland chloride reabsorption.

Nutritional success hinges on stringent enzymatic and micronutrient execution:

• Pancrelipase (PERT): Enteric-coated microtablets must be swallowed at the very initiation of all fat-containing intake. Dosing ranges from 2,000 to 4,000 lipase units per gram of ingested fat (capped at 10,000 lipase units/kg/day to prevent fibrosing colonopathy). Microtablets must never be chewed or crushed.
• Water-miscible ADEK: Daily administration of specially formulated water-soluble fat-soluble vitamins to avert retinal degeneration (A), rickets/osteomalacia (D), neuropathy (E), and coagulopathy (K).